Studies of the composition and structure of plasma lipoproteins. C- and N-terminal amino acids of the two nonidentical polypeptides of human plasma apolipoprotein A  by Kostner, Gerhard & Alaupovic, Petar
Volume 15, number 4 FEBS LETTERS July 1971 
STUDIES OF THE COMPOSITION AND STRUCTURE OF PLASMA LIPOPROTEINS. 
C- AND N-TERMINAL AMINO ACIDS OF THE TtiO NONIDENTICAL 
POLYPEPTIDES OF HUMAN PLASMA APOLIPOPROTEIN A 
Gerhard KOSTNER” and Petar ALAUI’OVIC 
Cardiovascular Section, Oklahoma Medical R esearch Foundation and1 
Department of Biochemistry, University of Oklahoma School of Medicine, 
Oklahoma City, Oklahoma 73104, USA 
Received 29 April 1971 
1. Introduction 
Although several authors suggested that the protein 
moiety of human plasma high density lipoproteins (HDL) 
(1.063-1.21 g/ m 1) consisted of nonidentical subunits 
[l-3] , Shore and Shore [4] were first to separate 
from this protein two polypeptides of similar mole- 
cular weight but different amino acid composition 
and electrophoretic mobilities on polyacrylamide gel. 
Characterized by threonine and glutamine as C-terminal 
amino acids, these polypeptides have been referred to 
as ‘R-Thr’ and ‘R-Glu’, respectively [4] . Although the 
iv-terminal amino acid analysis of these polypeptides 
has not yet been reported, previous studies indicated 
aspartic acid as the sole I\r-terminal amino acid of the 
intact protein moiety [5]. The occurrence of two non- 
identical polypeptides in HDL has been confirmed in- 
dependently by two groups of investigators [6,7]. 
We have recently shown [8] that lipoprotein A 
(LP-A) represents the major lipoprotein family in HDI 
and that its protein moiety, apolipoprotein A (ApoA), 
consists of a major and a minor polypeptide character- 
ized by amino acid composition and electrophoretic 
behavior similar, if not identical, to those of ‘R-‘lhr’ 
and ‘R-Glu’ polypeptides. In this report we present 
the results of terminal amino acid analysis of ApoA 
polypeptides. Contrary to the reports in the literature, 
* G. Kostner was a postdoctoral fellow of the Cardiovascular 
Section, Oklahoma Medical Research Foundation. Present 
address: Institut fiir F’hysiologische Chemie, Universitiit 
Graz, Graz, Austria. 
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both immunologically-homogeneous polypeptides 
were found to contain glutamine as the C-terminal 
amino acid. The major polypeptide was characterized 
by aspartic acid as the N-terminal amino acid, but 
failure of the minor polypeptide to react with dansyl 
chloride or dinitrofluorobenzene indicated that its 
N-terminal amino acid was blocked. 
2. Experimental procedure 
2.1. Isolation of human plasma HDL 
Lipoproteins were isolated from the plasma samples 
of healthy young men and women who had fasted over- 
night. The VLDL and LDL were removed by precipi- 
tation with 4% sodium phosphotungstate and 2 M 
MgQ according to the procedure by Burstein and 
Morfin [9]. The density of the filtrate was adjusted 
to 1.2 1 g/ml by adding solid NaBr and the solution 
was centrifuged in the No. 50 rotor of the Spinco 
Model L-2 ultracentrifuge at 140,000 g for 30 hr, at 
5’. The top layer (1.5-2.0 cm below the solution 
surface) was removed by a tube-slicing technique and 
washed by recentrifugation under identical conditions. 
After washing the top layer, consisting of HDL, was 
dialyzed against distilled water and lyophilized. 
2.2. Isolation of ApoA polypeptides 
The lyophilized HDL preparation was delipidized 
by five successive xtractions with ethanol-diethyl 
ether (3: 1, v/v, 5 X 50 ml solvent mixture/200 mg 
HDL) followed by two extractions with diethyl ether 
North-Holland Publishing Company - Amsterdam 
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(2 X 50 ml/200 mg HDL) at 4”. The initial step in the 
fractionation of ApoA polypeptides was carried out 
according to a modified procedure of Rudman et al. 
[7] . A sample of totally delipidized HDL was dis- 
solved in 1 M acetic acid (100 mg/6 ml) and placed 
on a column (200 X 2.5 cm) of Sephadex G-75. The 
column was eluted with 1 M acetic acid at a flow rate 
of 40 ml/hr. Fractions of 6.0 ml were collected and 
the protein was monitored by the absorbance at 280 
nm. Gel filtration resulted in separation of three peaks; 
first two peaks (ApoA-I and ApoA-II) consisted of 
two main ApoA polypeptides, while the third peak 
comprised the ApoC polypeptides. Each fraction was 
rechromatographed under identical conditions. The 
ApoA-I and ApoA-II polypeptide fractions were 
purified by column chromatography on DEAE-cellulose. 
The DEAE-cellulose (Cellex D, 0.39 meqlg capacity, 
Biorad, Richmond, Calif.) was washed successively 
with 1 M HCl, 1 M NaOH and distilled water, and 
equilibrated with 0.005 M phosphate buffer (pH 7.2) 
containing 8 M urea. Each polypeptide fraction was 
placed separately on the column (30 X 1.4 cm) and 
eluted with a linear gradient from 0.005 M to 0.06 M 
NaCl. Electrophoretically- and immunologically- 
homogeneous fractions ApoA-I and ApoA-II were 
combined, dialyzed against distilled water and lyo- 
philized. 
2.3. tmmunochemical and analytical methods 
The polypeptides were studied by double diffusion 
and immunoelectrophoresis in 1% agar and by 7.5% 
polyacrylamide gel electrophoresis according to the 
a 
Fig. 1. Polyacrylamide gel electrophoresis of ApoA-I (b) and 
ApoA-II (a). The anode is to the right. 
procedures described previously [lo]. Rabbit antihuman 
sera HDLa, LP-C and albumin were prepared and tested 
as previously described [ 1 l] . 
Analysis of C-terminal amino acids by hydrazinolysis 
and carboxypeptidases A and B, and of N-terminal 
amino acids by dansyl chloride and dinitrophenylation 
were carried out according to the procedures described 
in earlier papers [ 10, 121. Amino acid analysis was 
performed on a Beckman Model 120C analyzer accord- 
ing to an accelerated automatic procedure on spherical 
resins [l 1] . 
3. Results and discussion 
3.1. Characterization of ApoA polypep tides 
Both ApoA polypeptides gave single protein-staining 
bands on 7.5% polyacrylamide gel electrophoresis 
(fig. 1). However, the migration rate of ApoA-I was 
slower than that of ApoA-II. Each polypeptide ex- 
hibited a single immunoprecipitin line with antibodies 
to HDLa. In contrast to the ApoC peptides eluted as 
the third major peak from the Sephadex column, they 
gave a negative reaction with antibodies to LP-C. When 
tested simultaneously with antibodies to HDLa, the 
immunoprecipitin lines of ApoA polypeptides showed 
a non-identity reaction. The amino acid composition 
of ApoA-I was characterized by the absence of iso- 
leucine and halfcystine and that of ApoA-II by the 
absence of histidine, arginine and tryptophan. We 
concluded from these results that the ApoA-I 
corresponded to the ‘R-lhr’ peptide [4], fraction III 
[6] or fraction II peptide [7], and the ApoA-II to 
‘R-Glu7 [4] , fraction IV [6] or fraction III peptide 
t71* 
3.2. C-terminal amino acids 
Hydrazinolysis of ApoA-I peptide performed at 
four different reaction times (10,20,40 and 70 hr) 
resulted always in detection of only trace amounts of 
serine, glycine, threonine and alanine (0.05-0.1 mole 
per 22 X lo3 g of,peptide*). In a simultaneous 
control experiment, hydrazinolysis of glucagon yielded 
* Sedimentation equilibrium studies of ApoA polypeptlaes 
indicated that the average value for the molecular wei@ 
of ApoA-I was 22,000 and that of ApoA-II 12,500 (G. 
Kostner and P. Alaupovic, unpublished results). 
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Fig. 2. Release of ammo acids from ApoA-I polypeptide with 
carboxypeptidases A and B at 23”. 
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Fig. 3. Release of amino acids from ApoA-I polypeptide with 
carboxypeptidases A and B at 37’ 
only threonine in a significant amount (0.52 mole per 
mole of glucagon), but traces of serine, glycine and 
alanine were also detected. The absence of half-cystine 
from the amino acid composition and the negative 
results of hydrazinolysis experiments suggested the 
possible presence of either glutamine or asparagine as 
the C-terminal amino acid of ApoA-I. To explore this 
possibility, the ApoA-I polypeptide was digested with 
a mixture of carboxypeptidases A and B at 23 and 
3’ 
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Fig. 4. Release of amino acids from Ap:A-I polypeptide with 
carboxypeptidase A at 23 . 
37”. Results of these time studies (figs. 2 and 3) 
showed that the initial release of glutamine was 4 to 6 
times greater than that of threonine. Liberation of 
glutamine (1 .O molel17.2 X lo3 g protein) was almost 
completed after 30 mm at 37”. Digestion of ApoA-I 
polypeptide by carboxypeptidase A at 23’ (fig. 4) 
proceeded at a slower rate than that achieved by the 
mixture of both enzymes (fig. 2), but the initial release 
of glutamine was 15-20 times higher than that of 
threonine. To verify the sequence of C-terminal amino 
acids, the ApoA-I polypeptide was deaminated accord- 
ing to the procedure by Alexijev et al. [ 131 and the 
reaction product was digested by carboxypeptidase A. 
Although the results of this experiment showed (table 
1) an incomplete deamidation (40-42%) of the 
terminal amino acid, the identification of glutamic 
Table 1 
The release of amino acids from deaminated ApoA-I by diges- 
tion with carboxypeptidase A*. 
Ammo acids 
released 
pmoles/102 mg of peptide 
30 min 150 min 
Glu tamine 0.51 0.92 
Serine 0.47 0.58 
Glutamic acid 0.34 0.68 
Threonine 0.28 0.74 
z (glutamine + glutamic acid) 0.85 1.60 
* To increase the rate of hydrolysis of glutamic acid the 
enzymatic digestion was carried out at pH 6.0 and 37” [ 141. 
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Fig. 5. Release of amino acids from ApoA-I polypeptide with 
carboxypeptidases A and B at 37”. 
acid among the reaction products confirmed the 
identity and presence of glutamine as the C-terminal 
amino acid. The combined amount of glutamic acid 
and glutamine released after 30 min was three times 
as high as that of threonine. We concluded from these 
studies that glutamine is the C-terminal amino acid of 
ApoA-I polypeptide, followed in sequence by 
threonine and leucine. 
Whereas hydrazinolysis of ApoA-II’polypeptide 
resulted in detection of only trace amounts of serine, 
glycine and threonine, the enzymatic digestion with a 
mixture or individual carboxypeptidases A and B 
revealed glutamine as the~major C-terminal amino acid 
(fig. 5). The initial release of gutamine was four times 
greater than that of threonine; the release of glutamine 
with carboxypeptidase A leveled off after 8 to 10 hr 
(1 .O mole/l 2.5 X lo3 g protein). Analysis of the 
carboxypeptidase A digest (PH 6.0 at 37’) of a partially 
deamidated polypeptide revealed the presence of 
glutamic acid. We concluded from these results that 
ApoA-II contains also glutamine as the C-terminal 
amino acid. 
In contrast to the published report [4] suggesting 
threonine and glutamine as the C-terminal amino acids 
of the two major HDL polypeptides (‘R-Thr’ and 
‘R-Glu’), the results of our kinetic experiments with 
intact and deaminated preparations showed that both 
these immunochemically-homogeneous ApoA poly- 
peptides contain glutamine as the carboxyl terminus. 
Although not yet explainable, this discrepancy may 
be due either to the presence of contaminating pep- 
tides, methodological differences or microheterogeneity 
of ApoA-I polypeptide. It should be pointed out, how- 
ever, that Shore and Shore [4] also found glutamine 
to be the most rapidly released amino acid during the 
separate digestion of HDL protein by carboxypeptidase 
A and B at 25”. 
3.3. N-Terminal amino acids 
Qualitative N-terminal amino acid analysis of ApoA-I 
polypeptide by dansylation method indicated aspartic 
acid as the only major N-terminus. Dinitrophenylation 
of ApoA-I resulted in the paper chromatographic 
detection of a single ether soluble component (in 
addition to dinitrophenol and dinitroaniline) with the 
Rf value of DNP-aspartic acid. Hydrolysis of this 
DNP-derivative with saturated baryte-water [ 151 
yielded aspartic acid as the sole amino acid. The 
recovery of DNP-aspartic acid was 0.5 mole per 
22 X lo3 g of polypeptide. These results showed 
clearly that aspartic acid is the N-terminal amino acid 
of ApoA-I polypeptide. 
N-Terminal amino acid analyses of ApoA-II by 
either of these two methods were negative. Since no 
dansylated or DNP-amino acids could be detected in 
these experiments, we concluded that N-terminal 
amino acid of ApoA-II was blocked. 
Detection of identical N- or C-terminal amino acids 
in the consitutive polypeptides of human plasma apo- 
lipoproteins argues strongly against the present practice 
of coding or identifying polypeptides by their terminal 
amino acids. We propose, therefore, that the major 
polypeptide (former ‘R-Thr’) be designated as ApoA-I 
and the major polypeptide (former ‘R-Glu’) as 
ApoA-II. The ApoA-I is characterized by glutamine 
as the C-terminal and by aspartic acid as the N-terminal 
amino acid. The ApoA-II is characterized by glutamine 
as the C-terminal and by, as yet unknown, blocked 
N-terminal amino acid. 
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